skip to Main Content

WHO Members Urged To Support Resolution Delinking Cancer Drug Prices From R&D Costs

A group of civil society organisations and health experts have sent a letter to delegates to this month’s annual World Health Assembly urging support for a study on the delinkage of the costs of research and development from the prices of cancer medicines. Member states reportedly met on the issue today and are still undecided.
Author: Catherine Saez

Back To Top